Itau Unibanco Holding S.A. Karyopharm Therapeutics Inc. Transaction History

Itau Unibanco Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $13,272 - $28,285	-1,438 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $5,214 - $7,761	-1,207 Reduced 45.63%	1,438 $9,000
Q4 2018 Feb 13, 2019	BUY	$8.2 - $16.95 $393 - $813	48 Added 1.85%	2,645 $24,000
Q3 2018 Nov 13, 2018	SELL	$17.03 - $21.18 $1,243 - $1,546	-73 Reduced 2.73%	2,597 $44,000
Q2 2018 Aug 13, 2018	SELL	$12.0 - $19.88 $9,840 - $16,301	-820 Reduced 23.5%	2,670 $45,000
Q1 2018 May 14, 2018	BUY	$9.92 - $17.25 $25,077 - $43,608	2,528 Added 262.79%	3,490 $47,000
Q4 2017 Feb 09, 2018	BUY	$9.15 - $11.99 $1,088 - $1,426	119 Added 14.12%	962 $9,000
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $6,870 - $9,407	843	843 $29,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.